Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.48 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.48 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30431821 | 0.84 | MDM2 (0.49) | TAS1R3TAS1R1MDM2MEN1KMT2A | |
| SCHEMBL30863677 | 0.83 | MDM2 (0.49) | MDM2TP53 | |
| SCHEMBL10418082 | 0.83 | MDM2 (0.49) | MDM2TP53 | |
| SCHEMBL38666359 | 0.82 | MDM2 (0.53) | TAS1R3TAS1R1MDM2MEN1KMT2A | |
| SCHEMBL25356267 | 0.80 | MDM2 (0.48) | TAS1R3TAS1R1MDM2MEN1KMT2A | |
| SCHEMBL25356051 | 0.80 | MDM2 (0.48) | TAS1R3TAS1R1MDM2MEN1KMT2A | |
| SCHEMBL25356048 | 0.80 | MDM2 (0.48) | TAS1R3TAS1R1MDM2MEN1KMT2A | |
| SCHEMBL233300 | 0.79 | MDM2 (0.47) | MDM2MEN1KMT2AALDH1A1TP53 | |
| SCHEMBL13928511 | 0.79 | MDM2 (0.47) | MDM2MEN1KMT2AALDH1A1TP53 | |
| SCHEMBL31111371 | 0.79 | MDM2 (0.48) | MDM2MEN1KMT2AALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4673424-A1 | LIQUID PHASE PEPTIDE SUPPORT SYNTHESIS OF PEPTIDES AND PEPTIDOMIMETICS | Regeneron Pharmaceuticals, Inc. (US) | 2026-01-07 | — | — | EP | disclosed |
| WO-2024182268-A1 | LIQUID PHASE PEPTIDE SUPPORT SYNTHESIS OF PEPTIDES AND PEPTIDOMIMETICS | REGENERON PHARMACEUTICALS, INC. (US) | 2024-09-06 | — | — | WO | disclosed |